Quantcast
Last updated on April 18, 2014 at 15:29 EDT

Latest Digital pathology Stories

2012-05-07 02:31:49

TUCSON, Ariz., May 7, 2012 /PRNewswire/ -- Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the VENTANA Companion Algorithm p53 (DO-7) image analysis application using the VENTANA iScan Coreo Au scanner and VIRTUOSO software. Currently, Ventana is the only company offering an FDA-cleared p53 image analysis algorithm for determining p53 expression levels in breast cancer patients. Ventana is...

2012-04-22 23:00:53

The patented technology, now protected in both Europe and in the United States, enables perfect alignment of whole slide images at any magnification, independently of tissue type and staining. This is a central capability for the next generation of quantitative bio-marker analysis, and for time- and cost efficient whole slide stereology. Hoersholm, Denmark (PRWEB) April 23, 2012 Visiopharm A/S, a global leader in Quantitative Digital Pathology, announced today that the United States patent...

2012-04-18 22:21:58

LONDON, April 19, 2012 /PRNewswire/ -- Based on its recent analysis of web-based software platforms for tissue analysis and quantification, Frost & Sullivan recognise PathXL (Northern Ireland) with the 2012 European Web-based Software Platforms Enabling Technology Award. "PathXL's pioneering digital pathology solutions are highly versatile," notes Frost & Sullivan Senior Research Analyst Prasanna Vadhana Kannan. "They allow pathologists to adopt digital pathology for inter-laboratory...

2012-04-16 23:00:11

Hamamatsu will market and sell the entire suite of Visiopharm's QDP solutions, including CloudAnalysis, DeployedAnalysis, Stereology, and Application Protocol Packages (APPs) from Visiopharm´s new APPCenter. Hoersholm, Denmark (PRWEB) April 16, 2012 April 16, 2012 - Visiopharm, a leading provider of Quantitative Digital Pathology solutions, and Hamamatsu, a leading provider of whole slide scanners and data management solutions for digital pathology, announce today a non-exclusive...

2012-03-19 02:24:42

TUCSON, Ariz., March 19, 2012 /PRNewswire/ -- Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, is now introducing a novel platform for special stains, built on its industry-leading VENTANA BenchMark technology. Answering customers' challenges with their current process, the new BenchMark Special Stains platform offers walk-away automation, baking through staining including deparaffinization, random batch access, connectivity to the VANTAGE workflow solution, and...

2012-03-17 23:01:21

DigiPath to assist their digital pathology customers in adopting EasyCell assistant, an affordable and FDA cleared digital hematology solution. Henderson, Nevada, USA (PRWEB) March 17, 2012 DigiPath, Inc®, a provider of affordable, innovative and reliable digital pathology solutions, and Medica Corporation, a leading medical device designer and manufacturer with FDA and ISO compliant manufacturing facilities, have entered into a distribution agreement allowing DigiPath to assist their...

2012-03-13 06:00:00

TUCSON, Ariz., March 13, 2012 /PRNewswire/ -- Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the VENTANA Companion Algorithm Progesterone Receptor (PR) (1E2) image analysis application used with the VENTANA iScan Coreo Au scanner running VIRTUOSO software. This announcement comes on the heels of two other FDA clearances Ventana recently announced for the HER2 (4B5) and Ki-67 (30-9)...

2012-02-28 09:00:00

BRANFORD, Conn., Feb. 28, 2012 /PRNewswire/ -- HistoRx, the leader in quantitative immunohistochemistry, has earned two additional patents covering AQUA technology and critical elements of digital microscopy standardization. Combined with patents earned previously, these issuances by the US Patent & Trademark Office advance the Company's proprietary position in standardization of quantitative digital pathology to a dominant role in the industry. Challenges associated with the...

2012-02-27 06:00:00

TUCSON, Ariz., Feb. 27, 2012 /PRNewswire/ -- Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the VENTANA Companion Algorithm Ki-67 (30-9) image analysis application used with the VENTANA iScan Coreo Au scanner running VIRTUOSO software. Ventana is currently the only company offering an FDA cleared Ki-67 image analysis algorithm for determining Ki-67 expression levels in breast cancer...

2012-02-24 14:00:00

APPsolute Digital Pathology offers a novel approach to Quantitative Digital Pathology. Powered by CloudAnalysis and the APPCenter; currently featuring over 25 ready-to-use Analysis Protocol Packages (APPs). Hoersholm, Denmark (PRWEB) February 24, 2012 APPsolute Digital Pathology is a novel approach to Quantitative Digital Pathology (QDP); costs are reduced, the learning curve is minimized, and the common risks of adoption are eliminated. The Visiopharm APPCenter provides access to a library...